EP3402534 - CELLULAR BLEND FOR THE REGENERATION OF CHONDROCYTES OR CARTILAGE TYPE CELLS [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 04.06.2021 Database last updated on 24.07.2024 | |
Former | Request for examination was made Status updated on 19.10.2018 | ||
Former | The international publication has been made Status updated on 21.07.2017 | Most recent event Tooltip | 15.12.2023 | New entry: Renewal fee paid | Applicant(s) | For all designated states Spinalcyte, LLC 17006 Evergreen Elm Way Houston, TX 77059 / US | [2018/47] | Inventor(s) | 01 /
O'HEERON, Pete 17006 Evergreen Elm Way Houston, TX 77059 / US | [2018/52] |
Former [2018/47] | 01 /
O'HEERON, Pete 17300 Ei Camino Real Suite 110 Houston, TX 77058 / US | Representative(s) | J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB | [N/P] |
Former [2018/47] | J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB | Application number, filing date | 17739050.7 | 13.01.2017 | [2018/47] | WO2017US13449 | Priority number, date | US201662278635P | 14.01.2016 Original published format: US 201662278635 P | US201662413587P | 27.10.2016 Original published format: US 201662413587 P | [2018/47] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017123951 | Date: | 20.07.2017 | Language: | EN | [2017/29] | Type: | A1 Application with search report | No.: | EP3402534 | Date: | 21.11.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 20.07.2017 takes the place of the publication of the European patent application. | [2018/47] | Search report(s) | International search report - published on: | US | 20.07.2017 | (Supplementary) European search report - dispatched on: | EP | 16.08.2019 | Classification | IPC: | A61K48/00, A61K35/16, A61K35/19, A61K35/32, A61K35/33, A61K35/35, C12N5/077 | [2019/38] | CPC: |
C12N5/0655 (EP,US);
A61K35/32 (US);
A61K35/16 (US);
A61K35/19 (US);
A61K35/33 (US);
A61K35/35 (US);
|
Former IPC [2018/47] | A61K48/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/47] | Extension states | BA | 12.07.2018 | ME | 12.07.2018 | Title | German: | ZELLULÄRE MISCHUNG ZUR REGENERATION VON CHONDROZYTEN ODER KNORPELZELLEN | [2018/47] | English: | CELLULAR BLEND FOR THE REGENERATION OF CHONDROCYTES OR CARTILAGE TYPE CELLS | [2018/47] | French: | MÉLANGE CELLULAIRE DESTINÉ À LA RÉGÉNÉRATION DE CHONDROCYTES OU DE CELLULES DE TYPE CARTILAGINEUX | [2018/47] | Entry into regional phase | 12.07.2018 | National basic fee paid | 12.07.2018 | Search fee paid | 12.07.2018 | Designation fee(s) paid | 12.07.2018 | Examination fee paid | Examination procedure | deleted | Date on which the examining division has become responsible | 12.07.2018 | Examination requested [2018/47] | 01.04.2020 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time | 04.06.2020 | Amendment by applicant (claims and/or description) | 08.06.2021 | Despatch of a communication from the examining division (Time limit: M04) | 11.10.2021 | Reply to a communication from the examining division | 23.11.2022 | Despatch of a communication from the examining division (Time limit: M06) | 05.06.2023 | Reply to a communication from the examining division | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 04.06.2020 | Request for further processing filed | 04.06.2020 | Full payment received (date of receipt of payment) Request granted | 16.06.2020 | Decision despatched | Fees paid | Renewal fee | 15.01.2019 | Renewal fee patent year 03 | 29.06.2020 | Renewal fee patent year 04 | 29.03.2021 | Renewal fee patent year 05 | 28.01.2022 | Renewal fee patent year 06 | 12.01.2023 | Renewal fee patent year 07 | 14.12.2023 | Renewal fee patent year 08 | Penalty fee | Additional fee for renewal fee | 31.01.2020 | 04   M06   Fee paid on   29.06.2020 | 31.01.2021 | 05   M06   Fee paid on   29.03.2021 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]US2007184033 (SEVRAIN LIONEL C [US], et al) [Y] 1-15 * [0013][0021],[0057], [0083], [0127];; examples 1-4 *; | [Y]EP2034010 (OMRIX BIOPHARMACEUTICALS LTD [IL]) [Y] 1-15* Paragraphs [0033], [0051], [0055-57], [0063], [0068], [0073-83], [0087-90];; examples 1-3; claims 1-37 *; | [X]WO2010088775 (UNIV HEALTH NETWORK [CA], et al) [X] 1-6,8-12,15 * Paragraphs [0002], [0004], [0006], [0014-18], [0024], [0041], [00217], [00238], [00267];; examples 4, 5; claims 1-50 *; | [Y]WO2013070880 (SPINALCYTE LLC [US], et al) [Y] 1-15 * Broad outline paragraphs [0011], [0014-24], Details: pararaphs [0028-40], [0043], [0046];; example 1 *; | [Y]WO2014204806 (SPINALCYTE LLC [US]) [Y] 1-15 * Paragraphs [0013], [0014], [0018], [0028], [0043-44], [0047], [0078];; examples 1-2 *; | [XI]WO2015035395 (FIGENE LLC [US]) [X] 1-3,6-12,15 * Summary of invention: paragraphs [0009] - [0016] Detailed description: paragraphs [0022],[0032],[0034-35], [0037-38], (sox9 protein delivery by cells), [0040-41];; examples 1-2 * * Genes used in therapy: paragraphs [0044] - [0055],;; claims 1-14 * [I] 4,5,13,14 | International search | [A]WO2014026012 (ADVANCED MED TECH [US]) [A] 1* ; abstract *; | [X]WO2015035395 (FIGENE LLC [US]) [X] 1-3, 19-21, 23-26 and 28- 30 * ; abstract; para [0013], [0016], [0032], [0035], [0040], [0043], [0045], [0046], [0048], [0050], [0061], [0142], claim 2, claim 4 * |